共查询到20条相似文献,搜索用时 15 毫秒
1.
生态代谢组学研究进展 总被引:7,自引:1,他引:6
代谢组学指某一生物系统中产生的或已存在的代谢物组的研究,以质谱和核磁共振技术为分析平台,以信息建模与系统整合为目标。随着代谢组学中的研究方法与技术成为生态学研究的有力工具,生态代谢组学概念应运而生,即研究某一个生物体对环境变化的代谢物组水平的响应。理清代谢组学与生态代谢组学学科发展的脉络,综述代谢组学研究中的常用技术及其优势与局限性,论述代谢组学技术在生态学研究中的应用现状,展望代谢组学技术与其他系统生物学组学技术的结合在生态学中的应用前景,提出生态代谢组学研究者未来要完成的任务和面对的挑战。 相似文献
2.
van der Werf MJ Overkamp KM Muilwijk B Coulier L Hankemeier T 《Analytical biochemistry》2007,370(1):17-25
Achieving metabolome data with satisfactory coverage is a formidable challenge in metabolomics because metabolites are a chemically highly diverse group of compounds. Here we present a strategy for the development of an advanced analytical platform that allows the comprehensive analysis of microbial metabolomes. Our approach started with in silico metabolome information from three microorganisms-Escherichia coli, Bacillus subtilis, and Saccharomyces cerevisiae-and resulted in a list of 905 different metabolites. Subsequently, these metabolites were classified based on their physicochemical properties, followed by the development of complementary gas chromatography-mass spectrometry and liquid chromatography-mass spectrometry methods, each of which analyzes different metabolite classes. This metabolomics platform, consisting of six different analytical methods, was applied for the analysis of the metabolites for which commercial standards could be purchased (399 compounds). Of these 399 metabolites, 380 could be analyzed with the platform. To demonstrate the potential of this metabolomics platform, we report on its application to the analysis of the metabolome composition of mid-logarithmic E. coli cells grown on a mineral salts medium using glucose as the carbon source. Of the 431 peaks detected, 235 (=176 unique metabolites) could be identified. These include 61 metabolites that were not previously identified or annotated in existing E. coli databases. 相似文献
3.
《Médecine Nucléaire》2020,44(3):158-163
The metabolome, which represents the complete set of molecules (metabolites) of a biological sample (cell, tissue, organ, organism), is the final downstream product of the metabolic cell process that involves the genome and exogenous sources. The metabolome is characterized by a large number of small molecules with a huge diversity of chemical structures and abundances. Exploring the metabolome requires complementary analytical platforms to reach its extensive coverage. The metabolome is continually evolving, reflecting the continuous flux of metabolic and signaling pathways. Metabolomic research aims to study the biochemical processes by detecting and quantifying metabolites to obtain a metabolic picture able to give a functional readout of the physiological state. Recent advances in mass spectrometry (one of the mostly used technologies for metabolomics studies) have given the opportunity to determine the spatial distribution of metabolites in tissues. In a two-part article, we describe the usual metabolomics technologies, workflows and strategies leading to the implementation of new clinical biomarkers. In this second part, we first develop the steps of a metabolomic analysis from sample collection to biomarker validation. Then with two examples, autism spectrum disorders and Alzheimer's disease, we illustrate the contributions of metabolomics to clinical practice. Finally, we discuss the complementarity of in vivo (positron emission tomography) and in vitro (metabolomics) molecular explorations for biomarker research. 相似文献
4.
Mass spectrometry for the identification of the discriminating signals from metabolomics: current status and future trends 总被引:1,自引:0,他引:1
Werner E Heilier JF Ducruix C Ezan E Junot C Tabet JC 《Journal of chromatography. B, Analytical technologies in the biomedical and life sciences》2008,871(2):143-163
The metabolome is characterized by a large number of molecules exhibiting a high diversity of chemical structures and abundances, requiring complementary analytical platforms to reach its extensive coverage. Among them, atmospheric pressure ionization mass spectrometry (API-MS)-based technologies, and especially those using electrospray ionization are now very popular. In this context, this review deals with strengths, limitations and future trends in the identification of signals highlighted by API-MS-based metabolomics. It covers the identification process from the determination of the molecular mass and/or its elemental composition to the confirmation of structural hypotheses. Furthermore, some tools that were developed in order to address the MS signal redundancy and some approaches that could facilitate identification by improving the visualization and organization of complex data sets are also reported and discussed. 相似文献
5.
Psychogios N Hau DD Peng J Guo AC Mandal R Bouatra S Sinelnikov I Krishnamurthy R Eisner R Gautam B Young N Xia J Knox C Dong E Huang P Hollander Z Pedersen TL Smith SR Bamforth F Greiner R McManus B Newman JW Goodfriend T Wishart DS 《PloS one》2011,6(2):e16957
Continuing improvements in analytical technology along with an increased interest in performing comprehensive, quantitative metabolic profiling, is leading to increased interest pressures within the metabolomics community to develop centralized metabolite reference resources for certain clinically important biofluids, such as cerebrospinal fluid, urine and blood. As part of an ongoing effort to systematically characterize the human metabolome through the Human Metabolome Project, we have undertaken the task of characterizing the human serum metabolome. In doing so, we have combined targeted and non-targeted NMR, GC-MS and LC-MS methods with computer-aided literature mining to identify and quantify a comprehensive, if not absolutely complete, set of metabolites commonly detected and quantified (with today's technology) in the human serum metabolome. Our use of multiple metabolomics platforms and technologies allowed us to substantially enhance the level of metabolome coverage while critically assessing the relative strengths and weaknesses of these platforms or technologies. Tables containing the complete set of 4229 confirmed and highly probable human serum compounds, their concentrations, related literature references and links to their known disease associations are freely available at http://www.serummetabolome.ca. 相似文献
6.
Augustin Scalbert Lorraine Brennan Oliver Fiehn Thomas Hankemeier Bruce S. Kristal Ben van Ommen Estelle Pujos-Guillot Elwin Verheij David Wishart Suzan Wopereis 《Metabolomics : Official journal of the Metabolomic Society》2009,5(4):435-458
Mass spectrometry (MS) techniques, because of their sensitivity and selectivity, have become methods of choice to characterize
the human metabolome and MS-based metabolomics is increasingly used to characterize the complex metabolic effects of nutrients
or foods. However progress is still hampered by many unsolved problems and most notably the lack of well established and standardized
methods or procedures, and the difficulties still met in the identification of the metabolites influenced by a given nutritional
intervention. The purpose of this paper is to review the main obstacles limiting progress and to make recommendations to overcome
them. Propositions are made to improve the mode of collection and preparation of biological samples, the coverage and quality
of mass spectrometry analyses, the extraction and exploitation of the raw data, the identification of the metabolites and
the biological interpretation of the results. 相似文献
7.
Metabolomics: the chemistry between ecology and genetics 总被引:1,自引:0,他引:1
8.
Quantitative metabolomics based on gas chromatography mass spectrometry: status and perspectives 总被引:1,自引:0,他引:1
Koek MM Jellema RH van der Greef J Tas AC Hankemeier T 《Metabolomics : Official journal of the Metabolomic Society》2011,7(3):307-328
Metabolomics involves the unbiased quantitative and qualitative analysis of the complete set of metabolites present in cells,
body fluids and tissues (the metabolome). By analyzing differences between metabolomes using biostatistics (multivariate data
analysis; pattern recognition), metabolites relevant to a specific phenotypic characteristic can be identified. However, the
reliability of the analytical data is a prerequisite for correct biological interpretation in metabolomics analysis. In this
review the challenges in quantitative metabolomics analysis with regards to analytical as well as data preprocessing steps
are discussed. Recommendations are given on how to optimize and validate comprehensive silylation-based methods from sample
extraction and derivatization up to data preprocessing and how to perform quality control during metabolomics studies. The
current state of method validation and data preprocessing methods used in published literature are discussed and a perspective
on the future research necessary to obtain accurate quantitative data from comprehensive GC-MS data is provided. 相似文献
9.
Kyoungmi Kim Christine Mall Sandra L. Taylor Stacie Hitchcock Chen Zhang Hiromi I. Wettersten A. Daniel Jones Arlene Chapman Robert H. Weiss 《PloS one》2014,9(1)
While metabolomics has tremendous potential for diagnostic biomarker and therapeutic target discovery, its utility may be diminished by the variability that occurs due to environmental exposures including diet and the influences of the human circadian rhythm. For successful translation of metabolomics findings into the clinical setting, it is necessary to exhaustively define the sources of metabolome variation. To address these issues and to measure the variability of urinary and plasma metabolomes throughout the day, we have undertaken a comprehensive inpatient study in which we have performed non-targeted metabolomics analysis of blood and urine in 26 volunteers (13 healthy subjects with no known disease and 13 healthy subjects with autosomal dominant polycystic kidney disease not taking medication). These individuals were evaluated in a clinical research facility on two separate occasions, over three days, while on a standardized, weight-based diet. Subjects provided pre- and post-prandial blood and urine samples at the same time of day, and all samples were analyzed by “fast lane” LC-MS-based global metabolomics. The largest source of variability in blood and urine metabolomes was attributable to technical issues such as sample preparation and analysis, and less variability was due to biological variables, meals, and time of day. Higher metabolome variability was observed after the morning as compared to the evening meal, yet day-to-day variability was minimal and urine metabolome variability was greater than that of blood. Thus we suggest that blood and urine are suitable biofluids for metabolomics studies, though nontargeted mass spectrometry alone may not offer sufficient precision to reveal subtle changes in the metabolome. Additional targeted analyses may be needed to support the data from nontargeted mass spectrometric analyses. In light of these findings, future metabolomics studies should consider these sources of variability to allow for appropriate metabolomics testing and reliable clinical translation of metabolomics data. 相似文献
10.
Rabinowitz JD 《Expert review of proteomics》2007,4(2):187-198
Escherichia coli is among the simplest and best-understood free-living organisms. It has served as a valuable model for numerous biological processes, including cellular metabolism. Just as E. coli stood at the front of the genomic revolution, it is playing a leading role in the development of cellular metabolomics: the study of the complete metabolic contents of cells, including their dynamic concentration changes and fluxes. This review briefly describes the essentials of cellular metabolomics and its fundamental differentiation from biomarker metabolomics and lipidomics. Key technologies for metabolite quantitation from E. coli are described, with a focus on those involving mass spectrometry. In particular emphasis is given to the cell handling and sample preparation steps required for collecting data of high biological reliability, such as fast metabolome quenching. Future challenges, both in terms of data collection and application of the data to obtain a comprehensive understanding of metabolic dynamics, are discussed. 相似文献
11.
Dunn WB Broadhurst D Begley P Zelena E Francis-McIntyre S Anderson N Brown M Knowles JD Halsall A Haselden JN Nicholls AW Wilson ID Kell DB Goodacre R;Human Serum Metabolome 《Nature protocols》2011,6(7):1060-1083
Metabolism has an essential role in biological systems. Identification and quantitation of the compounds in the metabolome is defined as metabolic profiling, and it is applied to define metabolic changes related to genetic differences, environmental influences and disease or drug perturbations. Chromatography-mass spectrometry (MS) platforms are frequently used to provide the sensitive and reproducible detection of hundreds to thousands of metabolites in a single biofluid or tissue sample. Here we describe the experimental workflow for long-term and large-scale metabolomic studies involving thousands of human samples with data acquired for multiple analytical batches over many months and years. Protocols for serum- and plasma-based metabolic profiling applying gas chromatography-MS (GC-MS) and ultraperformance liquid chromatography-MS (UPLC-MS) are described. These include biofluid collection, sample preparation, data acquisition, data pre-processing and quality assurance. Methods for quality control-based robust LOESS signal correction to provide signal correction and integration of data from multiple analytical batches are also described. 相似文献
12.
13.
Patrick J. Horn Kent D. Chapman 《Metabolomics : Official journal of the Metabolomic Society》2014,10(2):337-348
Mass spectrometry (MS) is currently the most utilized analytical instrument for evaluating the metabolite composition of a biological sample at both the qualitative and quantitative level. The exponential growth of raw data generated through increasingly versatile mass spectrometers requires sophisticated algorithms to process and visualize the raw data to address biological questions. The structural and quantitative diversity of a single species’ metabolome (e.g. all metabolite species) under different experimental conditions itself forms a very large and complex dataset to analyze. We have developed a free, Java-based metabolomics application “Metabolite Imager” (www.metaboliteimager.com) that enables customized analysis and visualization of the metabolite distributions in tissues acquired through MS-based imaging approaches. Metabolite Imager algorithms perform customized targeted searching of metabolites through user-defined and publicly-available databases enabling the analysis of spatial distributions of large metabolite numbers in tissue sections. Metabolite Imager’s automated, two-dimensional image generator has several customizable features for producing high-resolution images. Additional Metabolite Imager algorithms support identifying targeted and unknown detected metabolites in selected tissue regions using spatially-based enrichment analysis that could impact metabolic engineering strategies. Co-localization algorithms of metabolites and selected ions by m/z enable analysis of precursor-product relationships in situ that will be important for expanding the biological context of metabolic pathways. 相似文献
14.
15.
Metabolomics 总被引:1,自引:0,他引:1
Metabolomics is the systematic identification and quantitation of all metabolites in a given organism or biological sample. The enhanced resolution provided by nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS), along with powerful chemometric software, allows the simultaneous determination and comparison of thousands of chemical entities, which has lead to an expansion of small molecule biochemistry studies in bacteria, plants, and mammals. Continued development of these analytical platforms will accelerate the widespread use of metabolomics and allow further integration of small molecules into systems biology. Here, recent studies using metabolomics in xenobiotic metabolism and genetically modified mice are highlighted. 相似文献
16.
Hiroshi Tsugawa Yuki Tsujimoto Masanori Arita Takeshi Bamba Eiichiro Fukusaki 《BMC bioinformatics》2011,12(1):131
Background
The goal of metabolomics analyses is a comprehensive and systematic understanding of all metabolites in biological samples. Many useful platforms have been developed to achieve this goal. Gas chromatography coupled to mass spectrometry (GC/MS) is a well-established analytical method in metabolomics study, and 200 to 500 peaks are routinely observed with one biological sample. However, only ~100 metabolites can be identified, and the remaining peaks are left as "unknowns". 相似文献17.
The revival of interest in cancer cell metabolism in recent years has prompted the need for quantitative analytical platforms for studying metabolites from in vivo sources. We implemented a quantitative polar metabolomics profiling platform using selected reaction monitoring with a 5500 QTRAP hybrid triple quadrupole mass spectrometer that covers all major metabolic pathways. The platform uses hydrophilic interaction liquid chromatography with positive/negative ion switching to analyze 258 metabolites (289 Q1/Q3 transitions) from a single 15-min liquid chromatography-mass spectrometry acquisition with a 3-ms dwell time and a 1.55-s duty cycle time. Previous platforms use more than one experiment to profile this number of metabolites from different ionization modes. The platform is compatible with polar metabolites from any biological source, including fresh tissues, cancer cells, bodily fluids and formalin-fixed paraffin-embedded tumor tissue. Relative quantification can be achieved without using internal standards, and integrated peak areas based on total ion current can be used for statistical analyses and pathway analyses across biological sample conditions. The procedure takes ~12 h from metabolite extraction to peak integration for a data set containing 15 total samples (~6 h for a single sample). 相似文献
18.
Biotechnology, including genetic modification, is a very important approach to regulate the production of particular metabolites
in plants to improve their adaptation to environmental stress, to improve food quality, and to increase crop yield. Unfortunately,
these approaches do not necessarily lead to the expected results due to the highly complex mechanisms underlying metabolic
regulation in plants. In this context, metabolomics plays a key role in plant molecular biotechnology, where plant cells are
modified by the expression of engineered genes, because we can obtain information on the metabolic status of cells via a snapshot
of their metabolome. Although metabolome analysis could be used to evaluate the effect of foreign genes and understand the
metabolic state of cells, there is no single analytical method for metabolomics because of the wide range of chemicals synthesized
in plants. Here, we describe the basic analytical advancements in plant metabolomics and bioinformatics and the application
of metabolomics to the biological study of plants. 相似文献
19.
Kanani H Chrysanthopoulos PK Klapa MI 《Journal of chromatography. B, Analytical technologies in the biomedical and life sciences》2008,871(2):191-201
Metabolomics being the most recently introduced "omic" analytical platform is currently at its development phase. For the metabolomics to be broadly deployed to biological and clinical research and practice, issues regarding data validation and reproducibility need to be resolved. Gas chromatography-mass spectrometry (GC-MS) will remain integral part of the metabolomics laboratory. In this paper, the sources of biases in GC-MS metabolomics are discussed and experimental evidence for their occurrence and impact on the final results is provided. When available, methods to correct or account for these biases are presented towards the standardization of a systematic methodology for quantitative GC-MS metabolomics. 相似文献
20.
Michael Witting 《Proteomics》2023,23(23-24):2300032